{"id":"https://openalex.org/W2134401416","doi":"https://doi.org/10.1186/s12933-014-0162-3","title":"Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE","display_name":"Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-08","ids":{"openalex":"https://openalex.org/W2134401416","doi":"https://doi.org/10.1186/s12933-014-0162-3","mag":"2134401416","pmid":"https://pubmed.ncbi.nlm.nih.gov/25582325","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4299541"},"language":"en","primary_location":{"id":"doi:10.1186/s12933-014-0162-3","doi":"https://doi.org/10.1186/s12933-014-0162-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-014-0162-3","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-014-0162-3","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2134401416"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-014-0162-3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106073103","display_name":"Takanori Matsui","orcid":"https://orcid.org/0000-0001-9506-7571","observed_orcids":["https://orcid.org/0000-0001-9506-7571"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takanori Matsui","raw_affiliation_strings":["Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, 67 Asahi-machi, Kurume, 830-0011, Japan. matsui_takanori@med.kurume-u.ac.jp","Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, 67 Asahi-machi, Kurume, 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, 67 Asahi-machi, Kurume, 830-0011, Japan. matsui_takanori@med.kurume-u.ac.jp","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, 67 Asahi-machi, Kurume, 830-0011, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110778939","display_name":"Eriko Oda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eriko Oda","raw_affiliation_strings":["Department of Chemistry, Kurume University School of Medicine, Kurume, 830-0011, Japan. kumamaru@med.kurume-u.ac.jp","Department of Chemistry, Kurume University School of Medicine, Kurume 830-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Kurume University School of Medicine, Kurume, 830-0011, Japan. kumamaru@med.kurume-u.ac.jp","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Department of Chemistry, Kurume University School of Medicine, Kurume 830-0011, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083401692","display_name":"Yuichiro Higashimoto","orcid":"https://orcid.org/0000-0003-1382-8598","observed_orcids":["https://orcid.org/0000-0003-1382-8598"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuichiro Higashimoto","raw_affiliation_strings":["Department of Chemistry, Kurume University School of Medicine, Kurume, 830-0011, Japan. higashiy@med.kurume-u.ac.jp","Department of Chemistry, Kurume University School of Medicine, Kurume, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Kurume University School of Medicine, Kurume, 830-0011, Japan. higashiy@med.kurume-u.ac.jp","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Department of Chemistry, Kurume University School of Medicine, Kurume, Japan","institution_ids":["https://openalex.org/I105296287"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030113532","display_name":"Sho\u2010ichi Yamagishi","orcid":"https://orcid.org/0000-0003-0102-0823","observed_orcids":["https://orcid.org/0000-0003-0102-0823"]},"institutions":[{"id":"https://openalex.org/I105296287","display_name":"Kurume University","ror":"https://ror.org/057xtrt18","country_code":"JP","type":"education","lineage":["https://openalex.org/I105296287"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sho-ichi Yamagishi","raw_affiliation_strings":["Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, 67 Asahi-machi, Kurume, 830-0011, Japan. shoichi@med.kurume-u.ac.jp","Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, 67 Asahi-machi, Kurume, 830-0011, Japan. shoichi@med.kurume-u.ac.jp","institution_ids":["https://openalex.org/I105296287"]},{"raw_affiliation_string":"Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030113532"],"corresponding_institution_ids":["https://openalex.org/I105296287"],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":{"value":4290,"currency":"USD","value_usd":4290},"fwci":10.2901,"has_fulltext":true,"cited_by_count":130,"citation_normalized_percentile":{"value":0.99558233,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"14","issue":"1","first_page":"1","last_page":"1"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyridinium","display_name":"pyridinium","score":0.6539999842643738},{"id":"https://openalex.org/keywords/receptor-for-advanced-glycation-end-products","display_name":"receptor for advanced glycation end products","score":0.8769999742507935},{"id":"https://openalex.org/keywords/rage","display_name":"RAGE","score":0.8029999732971191},{"id":"https://openalex.org/keywords/endothelial-cells","display_name":"endothelial cells","score":0.7950000166893005},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9430000185966492},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9940000176429749},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.628000020980835},{"id":"https://openalex.org/keywords/dna-aptamers","display_name":"DNA aptamers","score":0.8970000147819519},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.8550000190734863},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.9449999928474426},{"id":"https://openalex.org/keywords/vcam-1","display_name":"VCAM-1","score":0.9769999980926514},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.7860000133514404},{"id":"https://openalex.org/keywords/diabetic-vascular-complications","display_name":"diabetic vascular complications","score":0.8069999814033508},{"id":"https://openalex.org/keywords/age-rage-signaling-pathway","display_name":"AGE-RAGE signaling pathway","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C2778857457","wikidata":"https://www.wikidata.org/wiki/Q153641","display_name":"Rage (emotion)","level":2,"score":0.9239552617073059},{"id":"https://openalex.org/C147990577","wikidata":"https://www.wikidata.org/wiki/Q25790","display_name":"Glycation","level":3,"score":0.8703837394714355},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.7413471937179565},{"id":"https://openalex.org/C2780545709","wikidata":"https://www.wikidata.org/wiki/Q21130552","display_name":"HMGB1","level":3,"score":0.6636067628860474},{"id":"https://openalex.org/C2777411675","wikidata":"https://www.wikidata.org/wiki/Q1232438","display_name":"Umbilical vein","level":3,"score":0.6346580982208252},{"id":"https://openalex.org/C2781272698","wikidata":"https://www.wikidata.org/wiki/Q423211","display_name":"Glyceraldehyde","level":4,"score":0.6266627311706543},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5384073257446289},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5348199009895325},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4179462194442749},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4052436947822571},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.399833619594574},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39947277307510376},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2837579548358917},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27311861515045166},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25786781311035156},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09095340967178345},{"id":"https://openalex.org/C2776317432","wikidata":"https://www.wikidata.org/wiki/Q412547","display_name":"Dehydrogenase","level":3,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067759","descriptor_name":"Receptor for Advanced Glycation End Products","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005985","descriptor_name":"Glyceraldehyde","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011726","descriptor_name":"Pyridinium Compounds","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061307","descriptor_name":"Human Umbilical Vein Endothelial Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12933-014-0162-3","doi":"https://doi.org/10.1186/s12933-014-0162-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-014-0162-3","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-014-0162-3","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3266645","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4299541","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4299541","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4299541/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovasc Diabetol","raw_type":"Text"},{"id":"pmid:25582325","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25582325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular diabetology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1186/s12933-014-0162-3","doi":"https://doi.org/10.1186/s12933-014-0162-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-014-0162-3","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-014-0162-3","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3834308612","display_name":"The mechanism of construction and cyclization of tetrapyrrole in the heme biosynthetic pathway","funder_award_id":"24550201","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G3859334163","display_name":"Development of DNA-aptamer raised against RAGE and its clinical application for cardiovascular disease and cancer","funder_award_id":"25293127","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G955061776","display_name":null,"funder_award_id":"25293127","funder_id":"https://openalex.org/F4320320912","funder_display_name":"Ministry of Education, Culture, Sports, Science and Technology"}],"funders":[{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2134401416.pdf","grobid_xml":"https://content.openalex.org/works/W2134401416.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W1509582521","https://openalex.org/W1516434930","https://openalex.org/W1529592271","https://openalex.org/W1559136693","https://openalex.org/W1580322195","https://openalex.org/W1802218256","https://openalex.org/W1963535697","https://openalex.org/W1982294133","https://openalex.org/W1982439504","https://openalex.org/W1984108619","https://openalex.org/W1996120056","https://openalex.org/W1996442754","https://openalex.org/W1996478420","https://openalex.org/W1998614770","https://openalex.org/W2009790546","https://openalex.org/W2016222018","https://openalex.org/W2024172672","https://openalex.org/W2027604422","https://openalex.org/W2047170474","https://openalex.org/W2047724792","https://openalex.org/W2051537136","https://openalex.org/W2058597871","https://openalex.org/W2062273929","https://openalex.org/W2065654211","https://openalex.org/W2066853164","https://openalex.org/W2066949987","https://openalex.org/W2081372738","https://openalex.org/W2081556030","https://openalex.org/W2082503109","https://openalex.org/W2083284128","https://openalex.org/W2087695672","https://openalex.org/W2094411506","https://openalex.org/W2094939617","https://openalex.org/W2096857883","https://openalex.org/W2099727335","https://openalex.org/W2103093482","https://openalex.org/W2104525153","https://openalex.org/W2108868980","https://openalex.org/W2115060813","https://openalex.org/W2115163080","https://openalex.org/W2115944392","https://openalex.org/W2119198856","https://openalex.org/W2125273214","https://openalex.org/W2129049321","https://openalex.org/W2129661948","https://openalex.org/W2130791906","https://openalex.org/W2133857970","https://openalex.org/W2138561622","https://openalex.org/W2141157874","https://openalex.org/W2147371753","https://openalex.org/W2169643396","https://openalex.org/W2315992005","https://openalex.org/W2327456390","https://openalex.org/W2333993280","https://openalex.org/W2739174192"],"related_works":["https://openalex.org/W2023497842","https://openalex.org/W2111867309","https://openalex.org/W1994269968","https://openalex.org/W3015955638","https://openalex.org/W2119198856","https://openalex.org/W1980763614","https://openalex.org/W2118332826","https://openalex.org/W1978611180","https://openalex.org/W1982294133","https://openalex.org/W2060161378"],"abstract_inverted_index":{"BACKGROUND:":[0],"We":[1],"have":[2],"previously":[3],"shown":[4],"that":[5,74,277,284,300,311],"serum":[6,64],"levels":[7,234],"of":[8,62,90,99,108,116,135,142,185,195,235,267,291,328],"glyceraldehyde-derived":[9,131],"advanced":[10],"glycation":[11],"end":[12],"products":[13],"(Gly-AGEs)":[14],"are":[15],"elevated":[16],"under":[17],"oxidative":[18,40],"stress":[19],"and/or":[20],"diabetic":[21,67],"conditions":[22],"and":[23,30,41,152,154,169,189,247,283,315,320,322],"associated":[24],"with":[25,51,92,144,167,225],"insulin":[26],"resistance,":[27],"endothelial":[28,45],"dysfunction":[29],"vascular":[31,83,243,344],"inflammation":[32],"in":[33,44,85,124,158,204,215,251,309,325,346],"humans.":[34],"Further,":[35],"Gly-AGEs":[36,117,137,176,310],"not":[37],"only":[38],"evoke":[39],"inflammatory":[42,153,321],"reactions":[43,324],"cells":[46],"(ECs)":[47],"through":[48],"the":[49,113,136,140,165,183,192,223,289,329],"interaction":[50,166,331],"a":[52,79,96,205,304,338],"receptor":[53],"for":[54,82,342],"AGEs":[55],"(RAGE),":[56],"but":[57],"also":[58,255],"mimic":[59],"vasopermeability":[60],"effects":[61,115,194,266],"AGE-rich":[63],"purified":[65],"from":[66],"patients":[68],"on":[69,118,197,269],"hemodialysis.":[70],"These":[71],"observations":[72],"suggest":[73],"Gly-AGE-RAGE":[75],"system":[76],"might":[77,302,336],"be":[78,303,337],"therapeutic":[80,340],"target":[81],"complications":[84],"diabetes.":[86,347],"However,":[87],"since":[88],"incubation":[89,141],"glyceraldehyde":[91],"proteins":[93],"will":[94],"generate":[95],"large":[97],"number":[98],"structurally":[100],"distinct":[101],"AGEs,":[102],"it":[103],"remains":[104],"unclear":[105],"what":[106],"type":[107],"AGE":[109,307],"structures":[110],"could":[111],"mediate":[112],"deleterious":[114,265],"ECs.":[119],"AIMS":[120],"AND":[121],"METHODS:":[122],"Therefore,":[123],"this":[125],"study,":[126],"we":[127],"examined":[128],"(1)":[129],"whether":[130],"pyridinium":[132],"(GLAP),":[133],"one":[134],"generated":[138],"by":[139,217,222,257,332],"lysine":[143],"glyceraldehyde,":[145],"elicited":[146,317],"reactive":[147],"oxygen":[148],"species":[149],"(ROS)":[150],"generation":[151,203,214,319],"thrombogenic":[155,323],"gene":[156],"expression":[157],"human":[159],"umbilical":[160],"vein":[161],"ECs":[162],"(HUVECs)":[163],"via":[164],"RAGE":[168,188,282,314],"(2)":[170],"if":[171],"DNA":[172],"aptamers":[173],"raised":[174],"against":[175],"or":[177,180,260,286,334],"GLAP":[178,186,196,200,208,230,268,278,292,301],"(AGE-aptamer":[179],"GLAP-aptamer)":[181],"inhibited":[182,288],"binding":[184,290],"to":[187,281,293,313],"subsequently":[190,316],"suppressed":[191,256],"harmful":[193],"HUVECs.":[198,270,326],"RESULTS:":[199],"stimulated":[201],"ROS":[202,213,318],"bell-shaped":[206],"manner;":[207],"at":[209],"10":[210],"\u03bcg/ml":[211,229],"increased":[212],"HUVECs":[216],"40%,":[218],"which":[219,253],"was":[220],"blocked":[221,263],"treatment":[224],"RAGE-antibody":[226],"(RAGE-Ab).":[227],"Ten":[228],"significantly":[231,262],"up-regulated":[232],"mRNA":[233],"RAGE,":[236],"monocyte":[237],"chemoattractant":[238],"protein-1,":[239],"intercellular":[240],"adhesion":[241,245],"molecule-1,":[242],"cell":[244],"molecule-1":[246],"plasminogen":[248],"activator":[249],"inhibitor-1":[250],"HUVECs,":[252],"were":[254],"RAGE-Ab.":[258],"AGE-aptamer":[259,285,333],"GLAP-aptamer":[261,287,335],"these":[264],"Moreover,":[271],"quartz":[272],"crystal":[273],"microbalance":[274],"analyses":[275],"revealed":[276],"actually":[279],"bound":[280,312],"RAGE.":[294],"CONCLUSIONS:":[295],"The":[296],"present":[297],"study":[298],"suggests":[299],"main":[305],"glyceraldehyde-related":[306],"structure":[308],"Blockade":[327],"GLAP-RAGE":[330],"novel":[339],"strategy":[341],"preventing":[343],"injury":[345]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2134401416","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":27},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
